Insider Transactions in Q4 2025 at Lyell Immunopharma, Inc. (LYEL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2025
|
Veronica Sanchez Bulis VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
239
-2.53%
|
$3,824
$16.1 P/Share
|
|
Nov 10
2025
|
Lynn Seely President and CEO |
SELL
Open market or private sale
|
Direct |
412
-0.61%
|
$6,592
$16.11 P/Share
|
|
Nov 10
2025
|
Stephen J. Hill Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
95
-0.6%
|
$1,520
$16.12 P/Share
|
|
Nov 10
2025
|
Gary K. Lee Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
138
-0.89%
|
$2,208
$16.16 P/Share
|